Gates Foundation Backs Innovative Reproductive and HIV Research at ONPRC
Trusted by teams at
Description
The Bill & Melinda Gates Foundation is funding several research projects at ONPRC, covering topics from contraceptive innovation to HIV biomarker discovery and advanced drug delivery systems. These grants support ongoing scientific research through at least November 2026.
Contract Details
Contract Amount
$35,494 (Understanding endometrial responses to progestin contraceptives grant), $161,150 (Insight integration HIV biomarker project), $397,741 (Spatial transcriptomics for CIMC project), $100,463 (Multiomic spatial analysis for viral rebound project), $120,886 (Implanted refillable reservoir evaluation project)
Vendor
BILL & MELINDA GATES FOUNDATION
Agency
Oregon Health & Science University, OR
Contract Type
RESEARCH_GRANT
Document Date
January 22, 2026
Contract Term
Varies; project end dates: 11/30/26, 11/01/26, 06/30/26, 07/24/26
Renewal Date
2026-11-30
Renewal Info
Grants are time-limited, per project. Future renewals or supplements not explicitly mentioned.
More from BILL & MELINDA GATES FOUNDATION
More from Oregon Health & Science University
Oregon Health & Science University Board of Directors Public Meeting Agenda Packet 2026-06-17
Oregon Health & Science University Board of Directors Resolution 2026-02-01
OHSU Public Meeting of Finance & Audit Agenda Packet January 2026
OHSU Public Meeting of Finance & Audit Agenda Packet January 2026
OHSU Public Meeting of Finance & Audit Agenda Packet January 2026
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.